LIMARESIQUIMOD
UNII 2N985J9XZZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Limaresiquimod, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2N985J9XZZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2762923-39-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2N985J9XZZ

CAS Registry Number

2762923-39-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIMARESIQUIMOD

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203040

National Cancer Institute reference terminology for clinical and research data.

INN ID

12722

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

polymer

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Limaresiquimod. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIMARESIQUIMOD

Common Names & Synonyms

ACETYL AND 1-((2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO(4,5-C)QUINOLIN-4-YL)AMINO)-1,4,14-TRIOXO-6,9,12-TRIOXA-3,15-DIAZAOCTADECAN-18-OYL GROUPS LINKED TO 11 AND 8 PERCENT OF AMINO END GROUPS, RESPECTIVELY, OF THE DENDRITIC BLOCK POLYMER ((2,2-BIS((.OMEGA.-(.OMEGA.-OCTAAMINO-DENDROG3 -(AZANEDIYL((2S)-1-OXOHEXANE-1,2,6-TRIYL)))POLY(OXYETHYLENE)-.ALPHA.-YL)METHYL)PROPANE-1,3-DIYL)BIS(OXY))BIS(.OMEGA.-(.OMEGA.-OCTAAMINO-DENDROG3 -(AZANEDIYL((2S)-1-OXOHEXANE-1,2,6-TRIYL)))POLY(OXYETHYLENE)-.ALPHA.-YL) WHICH ITSELF IS CROSSLINKED THROUGH 81 PERCENT OF AMINO END GROUPS WITH A BIVALENT LINKER PRODUCED BY AMIDATION WITH .ALPHA.-(5-CARBOXYPENTANOYL)-.OMEGA.-((5-CARBOXYPENTANOYL)OXY)POLY(OXYETHYLENE)

LIMARESIQUIMOD [INN]

L-LYSINE, POLYMER WITH OXIRANE, ETHER WITH 2,2-BIS(HYDROXYMETHYL)-1,3-PROPANEDIOL (4:1), DIBLOCK, POLYMER WITH .ALPHA.-(5-CARBOXY-1-OXOPENTYL)-.OMEGA.-((5-CARBOXY-1-OXOPENTYL)OXY)POLY(OXY-1,2-ETHANEDIYL), REACTION PRODUCTS WITH ACETIC ANHYDRIDE AND 18-((2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO(4,5-C)QUINOLIN-4-YL)AMINO)-5,15,18-TRIOXO-7,10,13-TRIOXA-4,16-DIAZAOCTADECANOIC ACID

External Clinical & Regulatory Resources

Previous UNII2N9562JWVL

Next UNII2N9HM3X95F